نتایج جستجو برای: hiv 1 dna vaccine

تعداد نتایج: 3346593  

Journal: Vaccine Research 2014
Ali Eslamifar, Amitis Ramezani, Arezoo Aghakhani, Maryam Foroughi, Minoo Mohraz, Mohammad Banifazl,

Background: Due to their similar routes of transmission, human immunodeficiency virus (HIV) and hepatitis B virus (HBV) co-infection occurs considerably. HBV infection progresses more rapidly in HIV-infected patients. Therefore, HBV vaccination of all non-immune HIV infected patients is recommended. On the other hand, HIV-infected subjects have suboptimal responses to HBV vaccine. In this study...

Journal: :Journal of virology 2003
Danilo R Casimiro Ling Chen Tong-Ming Fu Robert K Evans Michael J Caulfield Mary-Ellen Davies Aimin Tang Minchun Chen Lingyi Huang Virginia Harris Daniel C Freed Keith A Wilson Sheri Dubey De-Min Zhu Denise Nawrocki Henryk Mach Robert Troutman Lynne Isopi Donna Williams William Hurni Zheng Xu Jeffrey G Smith Su Wang Xu Liu Liming Guan Romnie Long Wendy Trigona Gwendolyn J Heidecker Helen C Perry Natasha Persaud Timothy J Toner Qin Su Xiaoping Liang Rima Youil Michael Chastain Andrew J Bett David B Volkin Emilio A Emini John W Shiver

Cellular immune responses, particularly those associated with CD3(+) CD8(+) cytotoxic T lymphocytes (CTL), play a primary role in controlling viral infection, including persistent infection with human immunodeficiency virus type 1 (HIV-1). Accordingly, recent HIV-1 vaccine research efforts have focused on establishing the optimal means of eliciting such antiviral CTL immune responses. We evalua...

2012
Larisa I. Karpenko Alexey V. Danilenko Sergei I. Bazhan Elena D. Danilenko Galina M. Sysoeva Olga N. Kaplina Olga Y. Volkova Svetlana F. Oreshkova Alexander A. Ilyichev

This study is focusing on elucidation of the capacity of attenuated Salmonella enteritidis E23 (cya, crp) to serve as a vehicle for the rectal delivery of the DNA vaccine. Earlier for creation HIV-1 candidate DNA vaccine we have designed the polyepitope protein TCI (T-cell immunogen), which comprises over 80 CTL epitopes from subtype A, B and C HIV-1 proteins. The gene coding for TCI protein wa...

2017
Xiaoying Shen Rahul Basu Sheetal Sawant David Beaumont Sue Fen Kwa Celia LaBranche Kelly E Seaton Nicole L Yates David C Montefiori Guido Ferrari Linda S Wyatt Bernard Moss S Munir Alam Barton F Haynes Georgia D Tomaras Harriet L Robinson

An important goal of human immunodeficiency virus (HIV) vaccine design is identification of strategies that elicit effective antiviral humoral immunity. One novel approach comprises priming with DNA and boosting with modified vaccinia virus Ankara (MVA) expressing HIV-1 Env on virus-like particles. In this study, we evaluated whether the addition of a gp120 protein in alum or MVA-expressed secr...

2011
Adam K. Wheatley Marit Kramski Marina R. Alexander Jesse G. Toe Rob J. Center Damian F. J. Purcell

Small non-coding micro-RNAs (miRNA) are important post-transcriptional regulators of mammalian gene expression that can be used to direct the knockdown of expression from targeted genes. We examined whether DNA vaccine vectors co-expressing miRNA with HIV-1 envelope (Env) antigens could influence the magnitude or quality of the immune responses to Env in mice. Human miR-155 and flanking regions...

Alireza Tahamtan, Hamed Naziri, Khodayar Ghorban, Maryam Dadmanesh, Mohammad Barati,

Background: There is a growing interest in development of an effective adjuvant system for improving DNA vaccines. Recent findings have confirmed an important role for autophagy in both innate and adaptive immunity. The current study was undertaken to determine the efficacy of autophagy induction with Beclin-1, as a novel adjuvant system, in mice immunized with human papilloma virus (HPV) DNA v...

Introduction: Despite considerable efforts to control AIDS pandemic, it is still one of the significant infectious concerns worldwide. The advance in medical research has led to the development of highly active antiretroviral therapy with a considerable effect to suppress the disease. However, an effective vaccine capable of eradication the HIV pandemic is not available yet. Failure to develop ...

Journal: :Clinical science 2006
Rebekah L Puls Sean Emery

Although effective in reducing mortality, current antiretroviral therapy for HIV infection involves complex and expensive drug regimens that are toxic and difficult to take. Eradication of HIV reservoirs is not possible with existing therapies. The concept of therapeutic vaccination has been investigated to increase the potency and breadth of anti-HIV immune responses in order to delay or reduc...

Journal: :modares journal of medical sciences: pathobiology 2010
mehdi mahdavi massoumeh ebtekar kayhan azadmanesh fereidoun mahboudi hamidreza khorramkhorshid

objective: several vaccines against hiv have been investigated but none has been approved as an effective hiv vaccine. an approach that could induce stronger immune response against the pathogen is utilizing a multi-epitopic vaccine. this strategy was used in the design of several vaccines and resulted in improved immune responses. materials and methods: in this study a multi-epitopic fusion p...

Journal: Vaccine Research 2014
Arash Memarnejadian, Fatemeh Kohram, Haniyeh Aghababa, Mehdi Mahdavi, Mohammad Reza Aghasadeghi, Morteza Taghizadeh, Nima Khoramabadi, Samira Arabi, Zahra Shahosseini,

  Introduction : Designing an effective vaccine against human immunodeficiency virus (HIV)-1 is a global health priority . Multi-epitope vaccines offer several potential advantages that may be promising in case of mutable divergent pathogens such as HIV-1. Herein, a multiepitopic recombinant protein containing various HIV-1 antigens was expressed in E. coli cells and its immunogenicity in combi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید